Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth

Kimberley Hanson(University of East Anglia), Grant N. Wheeler(University of East Anglia), Karamallah Al‐Yousuf(University of East Anglia), Adam E. Hendry(University of East Anglia), Victoria Sherwood(Ninewells Hospital), Stephen D. Robinson(University of East Anglia), Darren W. Sexton(Liverpool John Moores University)
Oncotarget
November 27, 2018
Cited by 1


Related Papers